Prevalence of large vessel occlusion in patients presenting with acute ischemic stroke: a 10-year systematic review of the literature

N Lakomkin, M Dhamoon, K Carroll, IP Singh… - Journal of …, 2019 - jnis.bmj.com
Background Accurate assessment of the prevalence of large vessel occlusion (LVO) in
patients presenting with acute ischemic stroke (AIS) is critical for optimal resource allocation …

[HTML][HTML] Prospective, randomized, controlled pivotal trial of an ab interno implanted trabecular micro-bypass in primary open-angle glaucoma and cataract: two-year …

TW Samuelson, SR Sarkisian Jr, DM Lubeck, MC Stiles… - Ophthalmology, 2019 - Elsevier
Purpose Evaluate the safety and effectiveness of an ab interno implanted (iStent inject)
Trabecular Micro-Bypass System (Glaukos Corporation, San Clemente, CA) in combination …

A Schlemm canal microstent for intraocular pressure reduction in primary open-angle glaucoma and cataract: the HORIZON study

TW Samuelson, DF Chang, R Marquis, B Flowers… - Ophthalmology, 2019 - Elsevier
Objective To compare cataract surgery with implantation of a Schlemm canal microstent with
cataract surgery alone for the reduction of intraocular pressure (IOP) and medication use …

Three-year findings of the HORIZON Trial: a Schlemm canal microstent for pressure reduction in primary open-angle glaucoma and cataract

IIK Ahmed, DJ Rhee, J Jones, IP Singh, N Radcliffe… - Ophthalmology, 2021 - Elsevier
Purpose To report 3-year outcomes of the HORIZON study comparing cataract surgery (CS)
with Hydrus Microstent (Ivantis, Inc) implantation versus CS alone. Design Multicenter …

[HTML][HTML] Once-daily netarsudil versus twice-daily timolol in patients with elevated intraocular pressure: the randomized phase 3 ROCKET-4 study

AS Khouri, JB Serle, J Bacharach, DW Usner… - American journal of …, 2019 - Elsevier
Purpose To compare the intraocular pressure (IOP)-lowering efficacy and safety of
netarsudil once daily (QD) and timolol twice daily (BID). Design Double-masked …

Quality of life in primary open-angle glaucoma and cataract: an analysis of VFQ-25 and OSDI from the iStent inject® pivotal trial

TW Samuelson, IP Singh, BK Williamson… - American Journal of …, 2021 - Elsevier
Objective To assess quality of life (QOL) as measured by patient-reported outcomes (PRO)
within the iStent inject® pivotal trial. Design Randomized controlled trial analysis of …

[HTML][HTML] Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after …

SL Tyson, S Bafna, JP Gira, DF Goldberg… - Journal of Cataract & …, 2019 - Elsevier
Purpose To assess the efficacy and safety of a sustained-release intracanalicular
dexamethasone insert for the treatment of postoperative ocular inflammation and pain in …

Modern vitreolysis—YAG laser treatment now a real solution for the treatment of symptomatic floaters

IP Singh - survey of ophthalmology, 2020 - Elsevier
I review the background of laser floater treatment and address the differences between the
old technology and the new technology of YAG lasers. I also review some recent …

Excisional goniotomy vs trabecular microbypass stent implantation: a prospective randomized clinical trial in eyes with mild to moderate open-angle glaucoma

S Falkenberry, IP Singh, CJ Crane… - Journal of Cataract & …, 2020 - journals.lww.com
Purpose: To compare reduction in intraocular pressure (IOP) and IOP-lowering medication
in eyes undergoing excisional goniotomy with Kahook Dual Blade (KDB) vs iStent …

Spontaneous bilateral carotid-cavernous fistulas secondary to cavernous sinus thrombosis

F Al-Mufti, K Amuluru, M El-Ghanem, AR Changa… - …, 2017 - journals.lww.com
Bilateral carotid cavernous fistulas are rare entities that can cause debilitating symptoms
and can lead to more severe consequences if left untreated. Therefore, the recognition and …